V
58
2
KMX
42
-12
WMB
62
2
CVS
36
3
SEE
45
3
SLG
32
-2
GME
65
3
FAST
30
2
HAS
43
2
O
24
-11
MAC
53
5
ABBV
53
3
D
50
2
PAYX
38
2
NWS
58
2
BEN
36
4
SRE
49
4
AFL
32
2
CTAS
39
3
F
39
3
V
58
2
KMX
42
-12
WMB
62
2
CVS
36
3
SEE
45
3
SLG
32
-2
GME
65
3
FAST
30
2
HAS
43
2
O
24
-11
MAC
53
5
ABBV
53
3
D
50
2
PAYX
38
2
NWS
58
2
BEN
36
4
SRE
49
4
AFL
32
2
CTAS
39
3
F
39
3
Financhill
Back

Innovator US Eqty Accelerated 9 Buffer ETF - April Vs. Aligos Therapeutics Industry Stock Comparison

Sell
42

XBAP
Innovator US Eqty Accelerated 9 Buffer ETF - April

Last Price:
$34.18
Seasonality Move:
3.86%
Buy
69

ALGS
Aligos Therapeutics

Last Price:
$43.44
Seasonality Move:
-17.17%
Sell
42
Innovator US Eqty Accelerated 9 Buffer ETF - April (XBAP) is a Sell

Is Innovator US Eqty Accelerated 9 Buffer ETF - April a Buy, Sell or Hold?

  • The current Innovator US Eqty Accelerated 9 Buffer ETF - April [XBAP] share price is $34.21. The Score for XBAP is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • XBAP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
69
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $43.42. The Score for ALGS is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

XBAP Stock Price Chart

What is Innovator US Eqty Accelerated 9 Buffer ETF - April's stock price today?

  • The Innovator US Eqty Accelerated 9 Buffer ETF - April share price today is $34.21
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XBAP is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $43.42
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

XBAP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.06 Buy
Relative Strength Index (14 RSI): 58.33 Buy
Chaikin Money Flow: 8035 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.04 - 34.22) Buy
Bollinger Bands (100): (32.95 - 34.03) Buy

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.14 Buy
Relative Strength Index (14 RSI): 74.33 Buy
Chaikin Money Flow: 210748 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (27.82 - 40.1) Buy
Bollinger Bands (100): (6.77 - 28.07) Buy

XBAP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34.15 Buy
20-day SMA: 34.14 Buy
50-day SMA: 33.93 Buy
200-day SMA: 32.57 Buy
8-day EMA: 34.14 Buy
20-day EMA: 34.1 Buy
50-day EMA: 33.9 Buy
200-day EMA: 32.67 Buy

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.78 Buy
20-day SMA: 36.11 Buy
50-day SMA: 23.97 Buy
200-day SMA: 16.97 Buy
8-day EMA: 40.32 Buy
20-day EMA: 35.95 Buy
50-day EMA: 27.43 Buy
200-day EMA: 19.22 Buy

Innovator US Eqty Accelerated 9 Buffer ETF - April Earnings Growth & XBAP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.65 per share, and a decrease next year of $0.14 per share.

Innovator US Eqty Accelerated 9 Buffer ETF - April Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):